China vaccinated 60,000 people: Result awaited

▴ China vaccinated 60,000 people: Result awaited
Chinese volunteers undergoes realtime vaccine trial

More than 60,000 volunteers have received one of the four Chinese candidates for the coronavirus vaccine “without presenting significant adverse effects,” a senior official from the Ministry of Science and Technology of China said Tuesday.

In a press conference of the Executive on the advancement of vaccines in China, the deputy director of the Social Development department Tian Baoguo said the country has already partially or totally developed 13 vaccines in Phase 3 of clinical trials.

“Adverse effects are common and normal in a vaccine candidate. Of the 60,000 people who have received the vaccine, some have had mild adverse effects, such as swelling at the vaccination site or fever, but no serious side effects have been reported,” he said.

Liu Jingzhen, president of the state-owned China National Biotechnology Group – which belongs to pharmaceutical giant Sinopharm – said the conglomerate is ready to mass-produce the vaccine once tests conclude and that it could manufacture more than 1 billion doses in 2021.

The director of the Center for the Development of Science and Technology of the National Health Commission Zheng Zhongwei said the price “will vary” depending on the type of vaccine, although “it will not be determined by supply and demand but by the technology used and the cost and scale of production.”

“It will be an acceptable price for the general public. The inactivated vaccine will cost more than the rest,” Zheng said.

He denied that China has launched a “vaccine diplomacy” with all the tests it carries out in various countries, many of them developing.

“What China does is work with other countries to develop the vaccine and contribute to making it safe and available to those who need it,” said Zheng, who gave as an example the entry of the Asian country into COVAX, the global platform for COVID-19 vaccine research.

The official also said the vaccines the country has administered since July for special cases have not shown any adverse effects, and that their “use has followed a rigorous scientific process approved by authorities.”

Zheng said Chinese citizens working abroad have already received these vaccines on a voluntary basis.

“China still faces a great challenge, both from imported cases and small outbreaks seen in recent months. We have to protect public workers, those traveling abroad or port personnel, and make sure they are not infected,” he said.

China aims to become the first country in the world to produce a large-scale vaccine against COVID-19, for which it has half a dozen developing countries – including several Latin American – participating in the final phase of clinical trials from various projects.

Zheng said last month that China plans to manufacture 610 million doses of the coronavirus vaccine before the end of this year and 1 billion in 2021, but did not advance a date for the vaccines to be applied massively.

Tags : #China #ChinaVaccine #ChinaNationalBiotechnologyGroup #TianBaoguo #LatestCovidVaccineNewsOct21

About the Author


Team Medicircle

Related Stories

Loading Please wait...
-Advertisements-


Trending Now

Dupixent approved by European Commission as first and only biologic medicine for children aged 6 to 11 years with severe atopic dermatitisNovember 30, 2020
DRDO increases number of ICU beds to 500 in Sardar Vallabhbhai Patel COVID Hospital at Delhi CanttNovember 30, 2020
COVID-19 recovery rate in country improves to 93.81 pctNovember 30, 2020
Gestational diabetes - Will it affect my baby? November 30, 2020
PM to interact with 3 teams involved in developing COVID-19 vaccine.November 30, 2020
Uttarakhand govt makes Covid-19 test mandatory for entry November 30, 2020
Unichem gets US FDA approval for Atenolol and Chlorthalidone TabletsNovember 30, 2020
Dr Reddy’s buys select anti-allergy brands from Glenmark in Russia and other CIS countries November 30, 2020
Government Launches Mission COVID Suraksha to accelerate Indian COVID-19 Vaccine Development November 30, 2020
71% of the daily fatalities contributed by eight States/UT - Delhi, Maharashtra, WB, Haryana, Punjab, Kerala, Uttar Pradesh and RajasthanNovember 30, 2020
Rajasthan govt decides to close schools, colleges, cinema, entertainment parks in state till Dec 31 November 30, 2020
India Covid-19 News Updates :Nov 29, 2020November 29, 2020
PM congratulates scientists on progress of Covid19 vaccine at Bharat BiotechNovember 28, 2020
COVID-19 recovery rate in country stands at 93.68 percent.November 28, 2020
Vertex Pharma received European Commission Approval for SYMKEVI With KALYDECONovember 28, 2020
Co-Diagnostics JV CoSara Diagnostics receives clearance from CDSCO for COVID-19 2-Gene Multiplex TestNovember 28, 2020
SAL unveils new pharma and perishable facilities in Riyadh in time for COVID vaccines distributionNovember 28, 2020
Number of Covid tests per million population in country cross one lakh markNovember 28, 2020
How can I lower cholesterol with diet?November 28, 2020
Breakthrough in AML Treatment: GoldenBiotech reports new drug trial of Antroquinonol November 28, 2020